US · Healthcare

Sol Gel Technologies Ltd (SLGL)

Biotechnology

Sol Gel Technologies Ltd (SLGL) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SLGL

P/E ratio

25.00

Sol Gel Technologies Ltd (SLGL) — FAQ

What is SLGL's P/E ratio?

The price-to-earnings (P/E) ratio for Sol Gel Technologies Ltd (SLGL) is 25.00 (data as of 2026-05-23).

Does Sol Gel Technologies Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Sol Gel Technologies Ltd (SLGL). Check the MyAverix Finance app for the latest dividend data.

What sector is Sol Gel Technologies Ltd in?

Sol Gel Technologies Ltd (SLGL) is classified in the Healthcare sector (Biotechnology industry).

What exchange is SLGL listed on?

SLGL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)